Locally Ablative Therapies in Oligometastatic Breast Cancer
Results of this cohort study suggest that few patients with single-site dnMBC undergo surgical/ablative therapy, although BR+MT and BR only were associated with improved OS. However, if invasive interventions are considered for patients with single-site dnMBC, resection of the breast primary may be beneficial.
Authors
- Ian Halliday (ORCID: https://orcid.org/0000-0003-1840-6132)
- Meghan R. Flanagan (ORCID: https://orcid.org/0000-0002-2330-6374)
- Laura Horst Rosenberger (ORCID: https://orcid.org/0000-0002-6829-6747)
- Astrid Botty Van den Bruele
- Tori C Nierenberg
- Ton Wang
- Gayle A. DiLalla
- Samantha M. Thomas
- E. Shelley Hwang
- Jennifer K. Plichta
Institutions
- Duke University (US)
- University of Washington (US)
- Duke Medical Center (US)
- Duke University Hospital (US)
- Duke Cancer Institute
Publication Details
- Journal
- JAMA Surgery
- Published
- 2026-03-04
- DOI
- https://doi.org/10.1001/jamasurg.2026.0098
- Primary Topic
- Breast Cancer Treatment Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00